Pain control after total hip arthroplasty in sickle cell patients is challenging yet essential to prevent sickle cell crises or protracted hospital stays. We present a case of effective analgesia that lasted for weeks in a young opioid-tolerant female. This was achieved by the administration of glucocorticoids with different durations of action, dexamethasone sodium phosphate/methylprednisolone acetate, via a femoral/lateral femoral cutaneous nerve block placed preoperatively. Postoperatively, the patient's opioid demand was unchanged from her preoperative baseline. She met all the discharge requirements, including physical therapy targets, on postoperative day 2 and did not have any complications during the hospitalization.

Download full-text PDF

Source
http://dx.doi.org/10.1213/XAA.0000000000000877DOI Listing

Publication Analysis

Top Keywords

sickle cell
12
total hip
8
hip arthroplasty
8
arthroplasty sickle
8
dexamethasone sodium
8
sodium phosphate/methylprednisolone
8
phosphate/methylprednisolone acetate
8
effective pain
4
pain management
4
management total
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!